VEGFA and peripheral arterial disease: However, since the first clinical evidence of the effects ofgene therapy with vascular endothelial growth factor (VEGF) was observed in patientswith peripheral artery disease, to date only two angiogenic therapy drugs have beenapproved, one in Russia and another in Japan, which seem a very small number, in viewof the large volume of investment made in pre-clinical and clinical studies.